Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma-Reference-Cited by-同舟云学术

Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma

Published:2022-04-07 Issue:3 Volume:102 Page:209-219
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry Part B Clinical

Author:

Das Nupur¹^ORCID,Dahiya Meetu¹,Gupta Ritu¹^ORCID,Kumar Lalit²,Sharma Atul²,Rai Sandeep¹,Singh Saroj¹,Prajapati Vijay K.¹,Sahoo Ranjit K.²,Gogia Ajay²

Affiliation:

1. Laboratory Oncology Unit Dr. B.R. Ambedkar IRCH, All India Institute of Medical Sciences New Delhi India

2. Department of Medical Oncology Dr. B.R. Ambedkar IRCH, All India Institute of Medical Sciences New Delhi India

Funder

Department of Biotechnology, Government of West Bengal

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22068

Reference22 articles.

1. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

2. Analysis of bone marrow plasma cells in patients with solitary bone plasmacytoma;Bhaskar A.;Cancer Therapy,2009

3. Instability of Immunophenotype in Plasma Cell Myeloma

4. Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition;Das N.;Cytometry Part B: Clinical Cytometry,2022

5. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Issue highlights—May 2024;Cytometry Part B: Clinical Cytometry;2024-05

2. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10‐colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity;International Journal of Laboratory Hematology;2024-03-08

3. Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice;Clinical Lymphoma Myeloma and Leukemia;2023-11

4. Issue highlights—July 2023;Cytometry Part B: Clinical Cytometry;2023-07

5. Voyage of Measurable Residual Disease Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry;Indian Journal of Medical and Paediatric Oncology;2023-04-24